科学家开发了电子“cyborg”胰腺细胞,以监测和促进实验室培育的小岛的胰岛素生产,推进糖尿病治疗。 Scientists developed electronic "cyborg" pancreas cells to monitor and boost insulin production in lab-grown islets, advancing diabetes treatment.

研究人员通过将灵活的电子传感器嵌入实验室产生的小盘细胞,创建了“cyborg”胰腺类组织,从而能够实时监测与葡萄糖管制挂钩的电气活动。 Researchers have created "cyborg" pancreatic organoids by embedding flexible electronic sensors into lab-grown islet cells, enabling real-time monitoring of electrical activity tied to glucose regulation. 混合系统能够精确跟踪细胞成熟、刺激反应和基因表达,同时提供有针对性的电脉冲,以加强胰岛素的生产和功能。 The hybrid system allows for precise tracking of cell maturation, responses to stimuli, and gene expression, while also delivering targeted electrical pulses to enhance insulin production and function. 这种方法模仿自然生物节奏,可能有助于实验室培育的胰腺细胞适当成熟,提高它们调节血糖的能力。 This approach, which mimics natural biological rhythms, may help lab-grown pancreatic cells mature properly, improving their ability to regulate blood sugar. 该技术可以推进糖尿病的再生医学,有可能减少对捐赠器官和免疫抑制药物的依赖。 The technology could advance regenerative medicine for diabetes, potentially reducing reliance on donor organs and immunosuppressive drugs.